The FDA has published new guidance aimed at encouraging abuse-deterrent generic versions of existing opioid painkillers as part of the fight against the addiction crisis gripping America.
The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. In a dreaded complete response letter, the FDA said the benefits listed in the ...
AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl ...
Hosted on MSN1mon
Nutriband partners with Kindeva for opioid patch developmentThe Aversa™ Fentanyl patch is designed to incorporate Nutriband's proprietary abuse-deterrent technology, which uses taste aversion to discourage misuse and accidental exposure of opioid and ...
Some in the legislature are now pushing Senate Bill 480, which would weaken prior authorization in Indiana. If that happens, ...
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...
Aversa™ is an abuse-deterrent transdermal technology designed to prevent the misuse and accidental exposure of opioid drugs like fentanyl. The partnership aims to enhance the safety profile of ...
The Aversa™ Fentanyl patch is designed to incorporate Nutriband’s proprietary abuse-deterrent technology, which uses taste aversion to discourage misuse and accidental exposure of opioid and stimulant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback